Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
- S-4 Registration of securities issued in business combination transactions
- 2.4 EX-2.4
- 10.16 EX-10.16
- 10.18 EX-10.18
- 10.19 EX-10.19
- 10.20 EX-10.20
- 10.26 EX-10.26
- 10.27 EX-10.27
- 10.28 EX-10.28
- 10.29 EX-10.29
- 10.31 EX-10.31
- 10.32 EX-10.32
- 10.33 EX-10.33
- 23.1 EX-23.1
- 23.2 EX-23.2
- 99.5 EX-99.5
- 99.6 EX-99.6
- 99.7 EX-99.7
- 99.8 EX-99.8
- 99.9 EX-99.9
- 99.10 EX-99.10
- 99.11 EX-99.11
Associated filings
- 12 Nov 20 424B3 Prospectus supplement
- 12 Nov 20 EFFECT Notice of effectiveness
- 6 Nov 20 S-4/A Registration of securities issued in business combination transactions (amended)
- 28 Oct 20 S-4/A Registration of securities issued in business combination transactions (amended)
-
23 Sep 20 S-4 Registration of securities issued in business combination transactions
KANT similar filings
- 29 Aug 22 Registration of securities issued in business combination transactions
- 6 Nov 20 Registration of securities issued in business combination transactions (amended)
- 28 Oct 20 Registration of securities issued in business combination transactions (amended)
- 23 Sep 20 Registration of securities issued in business combination transactions
Filing view
External links
Exhibit 99.7
September 23, 2020
Proteostasis Therapeutics, Inc.
80 Guest Street, Suite 500
Boston, Massachusetts 02135
Consent to Reference in Registration Statement
Proteostasis Therapeutics, Inc. (the “Company”) has filed a Registration Statement on Form S-4 with the Securities and Exchange Commission under the Securities Act of 1933, as amended (the “Securities Act”). In connection therewith, I hereby consent, pursuant to Rule 438 of the Securities Act, to the reference to me in the proxy statement/prospectus/information statement included in such registration statement as a future member of the board of directors of the Company.
Sincerely,
/s/ N. Anthony Coles |
| N. Anthony Coles |